Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

NeuroSense Therapeutics Q1 EPS $(0.33) Down From $(0.24) YoY

Author: Happy Mohamed | June 01, 2023 08:49am

NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.33) per share. This is a 37.5 percent decrease over losses of $(0.24) per share from the same period last year.

Posted In: NRSN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist